Detalles de la búsqueda
1.
Medical comorbidities in patients with chronic lymphocytic leukaemia treated with idelalisib: analysis of two large randomised clinical trials.
Br J Haematol
; 192(4): 720-728, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32599655
2.
Safety and Efficacy of Andecaliximab (GS-5745) Plus Gemcitabine and Nab-Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study.
Oncologist
; 25(11): 954-962, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32812320
3.
Phase 1b study to investigate the safety and tolerability of idelalisib in Japanese patients with relapsed/refractory follicular lymphoma and chronic lymphocytic leukemia.
Jpn J Clin Oncol
; 50(12): 1395-1402, 2020 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32856068
4.
Matrix metalloproteinase-9 deficiency confers resilience in fibrodysplasia ossificans progressiva in a man and mice.
J Bone Miner Res
; 39(4): 382-398, 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38477818
5.
Multicenter phase II study of tivozanib (AV-951) and everolimus (RAD001) for patients with refractory, metastatic colorectal cancer.
Oncologist
; 18(4): 377-8, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23580238
6.
Development of second-generation VEGFR tyrosine kinase inhibitors: current status.
Curr Oncol Rep
; 13(2): 103-11, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21318618
7.
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study.
Lancet Oncol
; 11(1): 48-54, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19932054
8.
No increased bleeding events in patients with relapsed chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma treated with idelalisib.
Leuk Lymphoma
; 62(4): 837-845, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33297794
9.
Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1).
J Clin Oncol
; 39(9): 990-1000, 2021 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33577358
10.
Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival.
J Immunother Cancer
; 9(12)2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34893523
11.
Phase Ib Study of Tirabrutinib in Combination with Idelalisib or Entospletinib in Previously Treated Chronic Lymphocytic Leukemia.
Clin Cancer Res
; 26(12): 2810-2818, 2020 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32156743
12.
VEGF kinase inhibitors: how do they cause hypertension?
Am J Physiol Regul Integr Comp Physiol
; 297(1): R1-5, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19439616
13.
Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations.
Lancet Haematol
; 6(7): e366-e374, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31109827
14.
ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children.
Eur J Cancer
; 110: 74-85, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30772656
15.
Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia.
Hemasphere
; 6(4): e692, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35284802
16.
Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia.
Hemasphere
; 6(6): e729, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35747845
17.
Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma.
Leukemia
; 35(7): 2108-2113, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33328591
18.
Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy.
Eur J Cancer
; 51(1): 18-26, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25466509
19.
Phase I study of prolonged infusion Bryostatin-1 in patients with advanced malignancies.
Cancer Biol Ther
; 1(4): 409-16, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12432257
20.
Gemcitabine and irinotecan in locally advanced or metastatic biliary cancer: preliminary report.
Oncology (Williston Park)
; 17(9 Suppl 8): 23-6, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-14569844